Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Albemarle Corporation's Q3 2024 earnings demonstrated strong execution with volumetric growth in its Energy Storage division and year-over-year EBITDA growth in its Specialties and Ketjen segments.</li><li>The company's liquidity and leverage metrics are strong, with Albemarle maintaining leverage well below covenant limits and demonstrating operating cash conversion of over 100%.</li><li>Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.</li></ul>

Albemarle Corporation's Q3 2024 earnings demonstrated strong execution with volumetric growth in its Energy Storage division and year-over-year EBITDA growth in its Specialties and Ketjen segments.The company's liquidity and leverage metrics are strong, with Albemarle maintaining leverage well below covenant limits and demonstrating operating cash conversion of over 100%.Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

Albemarle Corporation: Will Its Volume Growth & Asset Utilization Help Bring A Shift In The Competitive Dynamics? - Major Drivers

IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

Event-Driven

<ul>
<li>The <a href="https://www.smartkarma.com/entities/arcadium-lithium-plc-2f9bfa3a-65a7-41f9-a157-e59603846420" target="_blank" data-smartkarma-citation="entities:40439:1" rel="noopener">Arcadium Lithium (ALTM US)</a> scheme meeting relating to <a href="https://www.smartkarma.com/entities/rio-tinto-ltd" target="_blank" data-smartkarma-citation="entities:13:1" rel="noopener">Rio Tinto Ltd (RIO AU)</a>’s US$5.85 offer is on 23 December. The transaction is expected to close in mid-2025.</li>
<li>The high current 12.3% spread reflects risk related to regulatory and shareholder approvals. The numerous required regulatory approvals pose a risk to completion and/or timing.  </li>
<li>Despite depressed lithium prices, the offer remains unattractive on several fronts. Blackwattle, which opposes the offer, could rally others to force a bump. Rio conceding to a bump is uncertain. </li>
</ul>


The Arcadium Lithium (ALTM US) scheme meeting relating to Rio Tinto Ltd (RIO AU)’s US$5.85 offer is on 23 December. The transaction is expected to close in mid-2025.
The high current 12.3% spread reflects risk related to regulatory and shareholder approvals. The numerous required regulatory approvals pose a risk to completion and/or timing.  
Despite depressed lithium prices, the offer remains unattractive on several fronts. Blackwattle, which opposes the offer, could rally others to force a bump. Rio conceding to a bump is uncertain. 


Arcadium Lithium (ALTM US/LTM AU): Scheme Vote on 23 December as Risks Mount

<ul><li>Albemarle Corporation's Q2 2024 earnings reveal a mix of operational successes and challenges reflective of the broader industry landscape.</li><li>During the quarter, the company reported net sales of $1.4 billion, a substantial decrease from $2.4 billion a year prior, primarily due to decreased pricing.</li><li>The loss attributable to Albemarle stood at $188 million, reflecting a significant downturn from profitability, with a diluted loss per share of $1.96.</li></ul>

Albemarle Corporation's Q2 2024 earnings reveal a mix of operational successes and challenges reflective of the broader industry landscape.During the quarter, the company reported net sales of $1.4 billion, a substantial decrease from $2.4 billion a year prior, primarily due to decreased pricing.The loss attributable to Albemarle stood at $188 million, reflecting a significant downturn from profitability, with a diluted loss per share of $1.96.

Albemarle Corporation: These Are The 7 Factors Driving Our 'Buy' Rating! - Financial Forecasts

<ul><li>Albemarle Corporation's first quarter earnings of 2024 revealed a net sales of $1.4 billion and adjusted EBITDA of $291 million.</li><li>Despite the decline of 47% year-over-year, which was caused largely by reduced prices, the firm experienced volumetric growth led by the energy storage segment.</li><li>The firm also confirmed its ability to navigate the market dynamism and confirmed delivery of over $9 million in productivity and restructuring cost savings, as part of efforts geared towards aligning costs with the current market situation.</li></ul>

Albemarle Corporation's first quarter earnings of 2024 revealed a net sales of $1.4 billion and adjusted EBITDA of $291 million.Despite the decline of 47% year-over-year, which was caused largely by reduced prices, the firm experienced volumetric growth led by the energy storage segment.The firm also confirmed its ability to navigate the market dynamism and confirmed delivery of over $9 million in productivity and restructuring cost savings, as part of efforts geared towards aligning costs with the current market situation.

Albemarle Corporation: A Tale Of  Expansion of New Facilities and Margin Recovery! - Major Drivers

<ul><li>Albemarle Corporation's 2023 earnings reported net sales of $9.6 billion, a 31% rise compared to 2022 with volume growth contributing 21% to the increase.</li><li>The energy storage sector delivered 35% volumetric growth.</li><li>The corporation's adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) for 2023 were $2.8 billion or $3.4 billion, excluding a lower-cost charge recorded in Q4.</li></ul>

Albemarle Corporation's 2023 earnings reported net sales of $9.6 billion, a 31% rise compared to 2022 with volume growth contributing 21% to the increase.The energy storage sector delivered 35% volumetric growth.The corporation's adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) for 2023 were $2.8 billion or $3.4 billion, excluding a lower-cost charge recorded in Q4.

Albemarle Corporation: Is The EV Demand Actually Flattening & Impacting Their Performance? - Major Drivers

United States

Albemarle Corporation produces specialty and fine chemicals.  The Company's chemicals are additives to or intermediates for plastics, polymers and elastomers, cleaning products, agricultural compounds, pharmaceuticals, photographic chemicals, drilling compounds, and biocides.  Albemarle produces the majority of its products in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Albemarle Corp (ALB US)

Albemarle Corporation: Will Its Volume Growth & Asset Utilization Help Bring A Shift In The Competitive Dynamics? - Major Drivers

Albemarle Corporation's Q3 2024 earnings demonstrated strong execution with volumetric growth in its Energy Storage division and year-over-year...

Baptista Research

Arcadium Lithium (ALTM US/LTM AU): Scheme Vote on 23 December as Risks Mount

A tempting wide gross spread comes with a health warning due to a long-dated offer with potential regulatory and shareholder approvals risks.

Arun George

Albemarle Corporation: These Are The 7 Factors Driving Our 'Buy' Rating! - Financial Forecasts

Albemarle Corporation's Q2 2024 earnings reveal a mix of operational successes and challenges reflective of the broader industry landscape. During...

Baptista Research

Albemarle Corporation: A Tale Of Expansion of New Facilities and Margin Recovery! - Major Drivers

Albemarle Corporation's first quarter earnings of 2024 revealed a net sales of $1.4 billion and adjusted EBITDA of $291 million. Despite the...

Baptista Research

Albemarle Corporation: Is The EV Demand Actually Flattening & Impacting Their Performance? - Major Drivers

Albemarle Corporation's 2023 earnings reported net sales of $9.6 billion, a 31% rise compared to 2022 with volume growth contributing 21% to the...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)